This issue was first addressed by Akbay et al., who demonstrated that forced expression of mutant EGFR in bronchial epithelial cells induced PD-L1 and that PD-L1 expression was reduced by EGFR inhibitors in EGFR-mutant NSCLC cell lines [76]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.